arcoxia 90mg film-coated tablets
merck sharp & dohme b.v. waarderweg 39, haarlem noord-holland, 2031 bn, netherlands - etoricoxib - film-coated tablet - etoricoxib 90 milligram(s) - antiinflammatory and antirheumatic products
arcoxia 60mg film-coated tablets
merck sharp & dohme b.v. waarderweg 39, haarlem noord-holland, 2031 bn, netherlands - etoricoxib - film-coated tablet - etoricoxib 60 milligram(s) - antiinflammatory and antirheumatic products
arcoxia 120mg film-coated tablets
merck sharp & dohme b.v. waarderweg 39, haarlem noord-holland, 2031 bn, netherlands - etoricoxib - film-coated tablet - etoricoxib 120 milligram(s) - antiinflammatory and antirheumatic products
indorem 100 suppositories
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - indometacin - suppository - indometacin 100 mg - antiinflammatory and antirheumatic products
lemsip flu 12hr ibuprofen + pseudoephedrine
reckitt benckiser healthcare (uk) limited 103-105 bath road slough sl1 3uh, united kingdom - ibuprofen, pseudoephedrine hydrochloride - modified-release capsule - ibuprofen 300 mg pseudoephedrine hydrochloride 45 mg - antiinflammatory and antirheumatic products
nurofen for children 100mg/5ml oral suspension
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - ibuprofen - oral suspension - ibuprofen 100 mg/5ml - antiinflammatory and antirheumatic products
solpadeine migraine ibuprofen & codeine tablets
omega pharma limited 1st floor, 32 vauxhall bridge road, london sw1v 2sa, united kingdom - codeine phosphate, hemihydrate, ibuprofen - film-coated tablet - codeine phosphate hemihydrate 12.8 mg ibuprofen 200 mg - antiinflammatory and antirheumatic products
efient
substipharm - prasugrel - acute coronary syndrome; angina, unstable; myocardial infarction - antithrombotic agents - efient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome (i.e. unstable angina, non-st-segment-elevation myocardial infarction [ua / nstemi] or st-segment-elevation myocardial infarction [stemi]) undergoing primary or delayed percutaneous coronary intervention (pci).
eptifibatide accord
accord healthcare s.l.u. - eptifibatide - myocardial infarction - antithrombotic agents - eptifibatide accord is intended for use with acetylsalicylic acid and unfractionated heparin.eptifibatide accord is indicated for the prevention of early myocardial infarction in adults presenting with unstable angina or non-q-wave myocardial infarction, with the last episode of chest pain occurring within 24 hours and with electrocardiogram (ecg) changes and/or elevated cardiac enzymes.patients most likely to benefit from eptifibatide accord treatment are those at high risk of developing myocardial infarction within the first 3-4 days after onset of acute angina symptoms including for instance those that are likely to undergo an early ptca (percutaneous transluminal coronary angioplasty).
integrilin
glaxosmithkline (ireland) limited - eptifibatide - angina, unstable; myocardial infarction - antithrombotic agents - integrilin is intended for use with acetylsalicylic acid and unfractionated heparin.integrilin is indicated for the prevention of early myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction with the last episode of chest pain occurring within 24 hours and with ecg changes and / or elevated cardiac enzymes.patients most likely to benefit from integrilin treatment are those at high risk of developing myocardial infarction within the first 3-4 days after onset of acute angina symptoms including for instance those that are likely to undergo an early percutaneous transluminal coronary angioplasty (ptca).